Does Dr. Gruenberg study asthma?

Yes, he specializes in research focused on new treatments for asthma, particularly for severe cases.

What treatments has Dr. Gruenberg researched?

He has researched biologic therapies, including omalizumab and anti-interleukin-5 therapies, which help manage severe asthma.

Is Dr. Gruenberg's work relevant to patients with severe asthma?

Absolutely, his research focuses on innovative treatments specifically aimed at patients with severe asthma who do not respond to standard therapies.

DANIEL RICHARD GRUENBERG, M.D.

PORTLAND, OR

Research Active

Internal Medicine - Hematology & Oncology NPI registered 21+ years 1 publication 2010 – 2010 NPI: 1467455238

Internal Medicine - Hematology & Oncology

Antibodies, Monoclonal Asthma Immunologic Factors Immunoglobulin E Interleukin-5 Oligonucleotides

Practice Location

9555 SW BARNES RD
PORTLAND, OR 97225-6663

Phone: (503) 297-7403

What does DANIEL GRUENBERG research?

Dr. Gruenberg studies new biologic therapies designed to treat asthma, especially for patients with severe cases who do not respond well to standard medications. He investigates treatments like omalizumab, which targets a specific type of antibody called immunoglobulin E, as well as anti-interleukin-5 therapies that help reduce inflammation in the airways. By tailoring treatments based on individual patient characteristics, Dr. Gruenberg aims to improve outcomes for those suffering from this chronic respiratory condition.

Key findings

Biologic therapies like omalizumab and anti-interleukin-5 therapies have shown strong evidence of effectiveness in treating severe asthma.
Omalizumab specifically targets immunoglobulin E, which plays a key role in allergic reactions associated with asthma.
Identifying specific characteristics of asthma in patients is crucial for finding the most effective treatment.

Frequently asked questions

Does Dr. Gruenberg study asthma?: Yes, he specializes in research focused on new treatments for asthma, particularly for severe cases.
What treatments has Dr. Gruenberg researched?: He has researched biologic therapies, including omalizumab and anti-interleukin-5 therapies, which help manage severe asthma.
Is Dr. Gruenberg's work relevant to patients with severe asthma?: Absolutely, his research focuses on innovative treatments specifically aimed at patients with severe asthma who do not respond to standard therapies.

Publications in plain English

Biologic therapies for asthma.

2010

Current opinion in pulmonary medicine

Gruenberg D, Busse W

Plain English
This research looks at new treatments for asthma, specifically biologic therapies that modify the immune system. Among these treatments, omalizumab, which targets immunoglobulin E, and anti-interleukin-5 therapies have shown strong evidence of effectiveness. These treatments are particularly helpful for patients with severe asthma who don't respond well to traditional medications, but finding the right treatment may require identifying specific characteristics of each patient's condition. Who this helps: This benefits patients with severe asthma and their doctors.

PubMed

Frequent Co-Authors

William Busse

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.